SBBP Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs...

Stats
Today's Volume	684 683
Average Volume	316 352
Market Cap	0.00
EPS	$-0.0700 ( 2021-08-05 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.111 (5.55%)

Insider Trading

Date	Person	Action	Amount	type
2021-10-05	Cdk Associates, L.l.c.	Sell	8 060 682	Ordinary Shares, $0.01 par value
2021-10-05	Cdk Associates, L.l.c.	Sell	2 220 000	Ordinary Shares Warrant (right to buy)
2021-10-05	Wilhoit Scott L.	Sell	109 510	Ordinary Shares
2021-10-05	Wilhoit Scott L.	Sell	649 000	Stock Option (Right to Buy)
2021-10-05	Kollender Richard S	Sell	234 229	Ordinary Shares

INSIDER POWER
0.00
Last 99 transactions
Buy: 6 188 774 \| Sell: 17 044 650

Volume Correlation

Long: 0.22 (neutral)

Short: -0.76 (moderate negative)

Signal:(42.06) Neutral

Strongbridge Biopharma Correlation

10 Most Positive Correlations
ORRF	0.896
VIEW	0.889
NTCT	0.866
PRCT	0.865
MMAC	0.86
RPRX	0.858
INDB	0.854
TRIT	0.854
HBCP	0.852
SABS	0.852

10 Most Negative Correlations
DFH	-0.93
COUP	-0.912
ICON	-0.91
RDUS	-0.909
CRVL	-0.902
FEYE	-0.9
CVT	-0.899
ARAY	-0.882
ACCD	-0.881
FTDR	-0.88

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Strongbridge Biopharma Correlation - Currency/Commodity

-0.84
( strong negative )

-0.80
( strong negative )

0.00
( neutral )

-0.75
( moderate negative )

-0.48
( neutral )

0.75
( moderate )

Strongbridge Biopharma Financials

Annual	2020
Revenue:	$30.73M
Gross Profit:	$28.52M (92.80 %)
EPS:	$-0.780

FY	2020
Revenue:	$30.73M
Gross Profit:	$28.52M (92.80 %)
EPS:	$-0.780

FY	2019
Revenue:	$21.71M
Gross Profit:	$17.89M (82.40 %)
EPS:	$-0.910

FY	2018
Revenue:	$18.03M
Gross Profit:	$14.04M (77.89 %)
EPS:	$0.690

Financial Reports:

No articles found.

Strongbridge Biopharma

Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs. The company offers Keveyis, an oral carbonic anhydrase inhibitor for treating hyperkalemic, hypokalemic, and related variants of primary periodic paralysis in the United States. Its clinical-stage product candidates include Recorlev, a cortisol synthesis inhibitor, which is in a Phase III clinical trials that for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that completed Phase II clinical trial for the treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is headquartered in Trevose, Pennsylvania.